C2/C6 ceramides and analogs (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameC2/C6 ceramides and analogs (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)
Drug Alias Namep21 activated kinase 1 agonists (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)PAK-1 agonists (University of Illinois at Chicago/University of Illinois at URBANA-CHAMPAIGN)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase PAK 1 stimulants
TargetsSerine/threonine-protein kinase PAK 1
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of IllinoisUniversity Of Illinois At Urbana–Champaign
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A